{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:58:25Z","timestamp":1780732705278,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Polycystic ovary syndrome (PCOS) contributes to metabolic and endocrine complications for women of reproductive age. We set out to assess the relationship between fetuin-A and anthropometric parameters, anthropometric indices, body composition, and atherogenic indices, as well as carbohydrate and lipid profile in women with polycystic ovary syndrome (PCOS). Methods. The study included 49 women with PCOS, aged between 18 and 39 years. All patients were tested for fetuin-A, fasting glucose and insulin, and lipid parameters, after oral-glucose administration were done. All of them underwent anthropometric measurements and body composition analyses such as BMI (Body Mass Index), WHR (Waist to Hip Ratio), WHtR (Waist to Height Ratio), BAI (Body Adiposity Index), VAI (Visceral Adiposity Index), LAP (Lipid Accumulation Product), BRI (Body Roundness Index), ABSI (A Body Shape Index), ABSI z-core (ABSI with added mortality risk in correlation with age and gender), AIP (Atherogenic Risk of Plasma), AC (Atherogenic Coefficient), Castelli risk index-I, and Castelli risk index-II. Results: Obesity was diagnosed in 18 patients (36.7%) based on BMI index and 7 patients (14.3%) based on BAI index. Significantly increased risk of metabolic complications was observed among 26 patients (53.1%) based on waist circumferences. Based on VAI index, risk of metabolic disease was observed among 17 women (34.7%). Dyslipidemia such as hypercholesterolemia, hypertriglyceridemia, and mixed hyperlipidemia was detected among 14 patients (28.6%), and insulin resistance was observed among 29 (59.2%). There was a positive correlation between fetuin-A and total cholesterol (r = 0.30, p = 0.0034). There was no statistically significant correlation between fetuin-A and all of the anthropometric measurements and anthropometric indices, atherogenic indices, and other biochemical parameters. Conclusion: Fetuin-A correlates with hypercholesterolemia. It is necessary to conduct further research regarding the relationship between fetuin-A concentrations and body composition, anthropometric indices, and metabolic disorders in women with PCOS. Surprisingly, the effects of concentration of fetuin-A and anthropometric indices (BAI, VAI, LAP, ABSI, ABSI z-core) in woman with PCOS have not been closely examined. Future studies that take these variables into account will need to be undertaken. More information on the relationship between fetuin-A concentrations and anthropometric indices would aid us in establishing a greater degree of accuracy on this matter.<\/jats:p>","DOI":"10.3390\/nu14194034","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T22:53:19Z","timestamp":1664405599000},"page":"4034","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome"],"prefix":"10.3390","volume":"14","author":[{"given":"Karolina","family":"Kulik-Kupka","sequence":"first","affiliation":[{"name":"Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"Jabczyk","sequence":"additional","affiliation":[{"name":"Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Nowak","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7583-8965","authenticated-orcid":false,"given":"Pawe\u0142","family":"Jagielski","sequence":"additional","affiliation":[{"name":"Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-066 Cracow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-5325","authenticated-orcid":false,"given":"Bartosz","family":"Hudzik","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, Poland"},{"name":"Third Department of Cardiology, Silesian Center for Heart Disease, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-800 Zabrze, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8670-8581","authenticated-orcid":false,"given":"Barbara","family":"Zubelewicz-Szkodzi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Nutrition-Related Disease Prevention, Department of Metabolic Disease Prevention, Faculty of Health Sciences in Bytom, Medical University of Silesia, 41-900 Bytom, Poland"},{"name":"Department of Endocrinology, District Hospital, 41-940 Piekary Slaskie, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"ref_1","first-page":"1735","article-title":"Analysis on endocrine and metabolic features of different phenotypes of polycystic ovary syndrome patients","volume":"29","author":"Li","year":"2016","journal-title":"Pak. J. Pharm. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4093\/dmj.2015.39.1.10","article-title":"Hepatokines as a link between obesity and cardiovascular diseases","volume":"39","author":"Yoo","year":"2015","journal-title":"Diabetes Metab. J."},{"key":"ref_3","first-page":"191","article-title":"The adipokine Chemerin and Fetuin-a serum levels in type 2 diabetes mellitus: Relation to obesity and inflammatory markers","volume":"25","author":"Bakkar","year":"2018","journal-title":"Egypt J. Immunol."},{"key":"ref_4","first-page":"4192940","article-title":"Low-dose spironolactone-pioglitazone-metformin normalizes circulating Fetuin-a concentrations in adolescent girls with polycystic ovary syndrome","volume":"2018","author":"Villarroya","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12944-018-0919-x","article-title":"Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation","volume":"17","author":"Khadir","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/jpem-2020-0524","article-title":"Evaluation of the pathophysiological role of Fetuin A levels in adolescents with polycystic ovary syndrome","volume":"34","author":"Kurnaz","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1568500","DOI":"10.3389\/fendo.2020.568500","article-title":"Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Woman","volume":"11","author":"Ramanjaneya","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S697","DOI":"10.1016\/j.dsx.2017.05.001","article-title":"A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome","volume":"11","author":"Gupta","year":"2017","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/13697137.2017.1316256","article-title":"Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?","volume":"20","author":"Gunning","year":"2017","journal-title":"Climacteric"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2147\/PPA.S119180","article-title":"Quality of life in overweight (obese) and normal-weight women with polycystic ovary syndrome","volume":"11","author":"Panico","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09513590802234253","article-title":"Body fat composition and distribution in women with polycystic ovary syndrome","volume":"24","author":"Cosar","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3892\/etm.2017.4094","article-title":"Obesity contributes more to increasing ApoB\/ApoA1 ratio than hyperandrogenism in PCOS women aged 20\u201338 years in China","volume":"13","author":"Zheng","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.atherosclerosis.2016.01.037","article-title":"Facilitatory effects of fetuin-A on atherosclerosis","volume":"246","author":"Naito","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Bourebaba, L., and Marycz, K. (2019). Pathophysiological Implication of Fetuin-A Glycoprotein in the Development of Metabolic Disorders: A Concise Review. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122033"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clnesp.2021.08.005","article-title":"Effect of l-carnitine supplementation on liver fat content and cardiometabolic indices in overweight\/obese women with polycystic ovary syndrome: A randomized controlled trial","volume":"46","author":"Sangouni","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jad.2020.12.135","article-title":"Effects of Alpha-2-HS-glycoprotein on cognitive and emotional assessment in prediabetic and diabetic subjects","volume":"282","author":"Mancuso","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1681\/ASN.2008060572","article-title":"Fetuin-A protects against atherosclerotic calcification in CKD","volume":"20","author":"Westenfeld","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","first-page":"e18553","article-title":"Investigating Fetuin-A and Paraoxonase-1 Activity as Markers in Polycystic Ovary Syndrome Based on Body Mass Index: A Prospective Case-Control Study","volume":"13","author":"Gurbuz","year":"2021","journal-title":"Cureus"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0891-5849(02)01436-3","article-title":"Expression of major HDL-associated antioxidant PON-1 is gender dependent and regulated during inflammation","volume":"34","author":"Zhang","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.11.004","article-title":"Effects of fetuin-A with diverse functions and multiple mechanisms on human health","volume":"88","author":"Icer","year":"2021","journal-title":"Clin. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-016-1132-1","article-title":"Visceral and subcutaneous adipose tissue express and secrete functional alpha2hsglycoprotein (fetuin a) especially in obesity","volume":"55","author":"Castelao","year":"2017","journal-title":"Endocrine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4981916","DOI":"10.1155\/2016\/4981916","article-title":"From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines","volume":"2016","author":"Sartori","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/09513590.2013.829442","article-title":"Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome","volume":"29","author":"Enli","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2013.01.023","article-title":"The serum protein \u03b12-Heremans-Schmid glycoprotein\/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome","volume":"169","author":"Abali","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00404-012-2494-0","article-title":"Serum Fetuin-A levels in women with polycystic ovary syndrome","volume":"286","author":"Gulhan","year":"2012","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"G\u0142uszek, S., Cie\u015bla, E., G\u0142uszek-Osuch, M., Kozie\u0142, D., Kiebzak, W., Wypch\u0142o, \u0141., and Suliga, E. (2020). Anthropometric indices and cut-off points in the diagnosis of metabolic disorders. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235121"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"825","DOI":"10.17219\/acem\/61100","article-title":"Usefulness of a new anthropometric indicator\u2014VAI (Visceral Adiposity Index) in the evaluation of metabolic and hormonal disorders in women with polycystic ovary syndrome","volume":"26","author":"Jagielski","year":"2017","journal-title":"Adv. Clin. Exp. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1038\/s41598-021-89307-z","article-title":"Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: A 9-year longitudinal study","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.12775\/JEHS.2021.11.08.001","article-title":"Anthropometric indicators of obesity. Are the new indicators a better predictor of body fat content than BMI?","volume":"11","author":"Walczyk","year":"2021","journal-title":"J. Educ. Health Sport"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/03630242.2021.1881697","article-title":"A body shape index (ABSI) and endometrial pathology","volume":"61","author":"Janas","year":"2021","journal-title":"Women Health"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Bawadi, H., Abouwatfa, M., Alsaeed, S., Kerkadi, A., and Shi, Z. (2019). Body Shape Index Is a Stronger Predictor of Diabetes. Nutrients, 11.","DOI":"10.3390\/nu11051018"},{"key":"ref_32","unstructured":"World Health Organization (2011). Waist Circumference and Waist-Hip Ratio, World Health Organization. Report of a WHO Expert Consultation."},{"key":"ref_33","unstructured":"Weir, C.B., and Jan, A. (2022, July 12). BMI Classification Percentile and Cut Off Points. [Updated 2021 Jun 29], StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541070\/."},{"key":"ref_34","first-page":"124","article-title":"Anthropometric measures of body composition used in obesity diagnosis\u2014An overview","volume":"51","author":"Lizak","year":"2016","journal-title":"Hyg. Pub. Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1038\/s41598-019-46187-8","article-title":"Visceral adiposity index (VAI), lipid accumulation product (LAP), and product of triglycerides and glucose (TyG) to discriminate prediabetes and diabetes","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_36","first-page":"A1","article-title":"Zalecenia kliniczne u chorych na cukrzyce\u0328 2016. Stanowisko Polskiego Towarzystwa Diabetologicznego","volume":"5","author":"Gumprecht","year":"2016","journal-title":"Diabetol. Klin."},{"key":"ref_37","first-page":"35","article-title":"Zaburzenia lipidowe u pacjent\u00f3w z chorobami uk\u0142adu sercowo- naczyniowego. Cze\u0328\u015b\u0107 I: Leczenie statynami","volume":"3","year":"2000","journal-title":"Przew. Lek."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1210\/jc.2009-0916","article-title":"Health Aging and Body Composition Study: Fetuin-A and change in body composition in older persons","volume":"94","author":"Ix","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1210\/jc.2010-0148","article-title":"Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss","volume":"95","author":"Brix","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.5603\/EP.2014.0051","article-title":"Fetuin-A levels in lean and obese women with polycystic ovary syndrome","volume":"65","author":"Kozakowski","year":"2014","journal-title":"Endokrynol. Pol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nawrocka-Rutkowska, J., Szyd\u0142owska, I., Jakubowska, K., Olszewska, M., Chlubek, S., Szczuko, M., and Starczewski, A. (2022). The role of Oxidative Stress in the Risk of Cardiovascular Disease and Identification of Risk Factors Using AIP and Castelli Atherogenicity Indicators in Patients with PCOS. Biomedicines, 10.","DOI":"10.3390\/biomedicines10071700"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12944-020-01410-8","article-title":"Evalutation of lipid ratios and triglyceride-glucose index as risk markers of insulin resistance in Iranian polycystic ovary syndrome women","volume":"19","author":"Kheirollahi","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.numecd.2008.05.004","article-title":"Insulin resistance and polycystic ovary syndrome","volume":"18","author":"Galluzzo","year":"2008","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/aje\/kww095","article-title":"Fetuin-A and Risk of Diabetes Independent of Liver Fat Content: The Multi-Ethnic Study of Atherosclerosis","volume":"185","author":"Aroner","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00404-014-3490-3","article-title":"Serum levels of fetuin A are increased in women with gestational diabetes mellitus","volume":"291","author":"Iyidir","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.105.588723","article-title":"Association Between Human Fetuin-A and the Metabolic Syndrome","volume":"113","author":"Ix","year":"2006","journal-title":"Circulation"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/19\/4034\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:41:07Z","timestamp":1760143267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/19\/4034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":48,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["nu14194034"],"URL":"https:\/\/doi.org\/10.3390\/nu14194034","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]}}}